• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

为在中低收入国家使用的新型葡萄糖自我监测技术制定目标产品特性。

Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.

机构信息

FIND, Geneva, Switzerland.

Health Action International, Amsterdam, Netherlands.

出版信息

PLoS One. 2024 Aug 26;19(8):e0309062. doi: 10.1371/journal.pone.0309062. eCollection 2024.

DOI:10.1371/journal.pone.0309062
PMID:39186719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11346918/
Abstract

AIMS

Most glucose self-monitoring devices have been developed with high-income countries in mind. We developed a target product profile (TPP) for new glucose self-monitoring technologies for users in low- and middle-income countries (LMICs).

METHODS

A draft TPP including 39 characteristics was developed by an expert group including diabetes specialists, device specialists, and people with diabetes, incorporating findings from qualitative research in LMICs. Each characteristic had minimal and optimal requirements for two use cases, frequent and sporadic use. Characteristics requiring refinement were identified via online survey. Characteristics with agreement level <90% for any requirement were reviewed by the expert group and amended as appropriate.

RESULTS

One characteristic (shelf life) had agreement <75% (both requirements for both use cases). Characteristics with agreement ≥75% and <90% for the frequent use case included infrastructure level, measurement cycle, duration of use before replacement, interchangeability, and calibration (both requirements), and activity log and price per month to end payer (minimal requirement). Intended use (both requirements), accuracy, and price per month to end payer (optimal requirement) had agreement ≥75% and <90% for the sporadic use case.

CONCLUSIONS

This TPP will inform developers on requirements for glucose self-monitoring technologies for LMICs, and support decision-makers in evaluating existing devices.

摘要

目的

大多数血糖自我监测设备都是针对高收入国家开发的。我们为中低收入国家(LMICs)的用户开发了新的血糖自我监测技术的目标产品概况(TPP)。

方法

一个包括 39 个特征的草案 TPP 由一个专家组开发,其中包括糖尿病专家、设备专家和糖尿病患者,纳入了在 LMICs 进行的定性研究的结果。每个特征对于两种使用情况(频繁使用和偶尔使用)都有最低和最佳要求。通过在线调查确定需要改进的特征。对于任何要求的一致性 <90%的特征,由专家组审查并进行适当修改。

结果

一个特征(保质期)的一致性 <75%(两种使用情况的两种要求)。对于频繁使用情况,具有一致性≥75%但 <90%的特征包括基础设施水平、测量周期、更换前的使用时间、可互换性和校准(两种要求)以及活动记录和每月向最终支付者支付的价格(最低要求)。对于偶尔使用情况,具有一致性≥75%但 <90%的特征包括预期用途(两种要求)、准确性和每月向最终支付者支付的价格(最佳要求)。

结论

该 TPP 将为开发 LMICs 的血糖自我监测技术的要求提供信息,并为决策者评估现有设备提供支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/11346918/3cb98864d11b/pone.0309062.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/11346918/3cb98864d11b/pone.0309062.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a815/11346918/3cb98864d11b/pone.0309062.g001.jpg

相似文献

1
Development of a target product profile for new glucose self-monitoring technologies for use in low- and middle-income countries.为在中低收入国家使用的新型葡萄糖自我监测技术制定目标产品特性。
PLoS One. 2024 Aug 26;19(8):e0309062. doi: 10.1371/journal.pone.0309062. eCollection 2024.
2
Development of a target product profile for a point-of-care cardiometabolic device.开发即时心血管代谢设备的目标产品特性。
BMC Cardiovasc Disord. 2021 Oct 9;21(1):486. doi: 10.1186/s12872-021-02298-7.
3
User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.用户对中低收入国家非侵入性和微创血糖自我监测设备的需求:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的定性研究。
BMJ Open. 2024 Feb 17;14(2):e076685. doi: 10.1136/bmjopen-2023-076685.
4
Best blood glucose meters.最佳血糖仪。
Consum Rep. 2012 Nov;77(11):52.
5
Hopes, dreams, and reality: the long road to pain-free glucose testing.希望、梦想与现实:通往无痛血糖检测的漫长之路。
Diabetes Technol Ther. 1999 Fall;1(3):315-20. doi: 10.1089/152091599317233.
6
Technology behind commercial devices for blood glucose monitoring in diabetes management: a review.商业用血糖仪在糖尿病管理中的技术:综述。
Anal Chim Acta. 2011 Oct 10;703(2):124-36. doi: 10.1016/j.aca.2011.07.024. Epub 2011 Jul 23.
7
How Can We Realize the Clinical Benefits of Continuous Glucose Monitoring?我们如何才能实现持续血糖监测的临床益处?
Diabetes Technol Ther. 2017 May;19(S2):S27-S36. doi: 10.1089/dia.2017.0021.
8
Design, fabrication, and feasibility analysis of a colorimetric detection system with a smartphone for self-monitoring blood glucose.用于自我监测血糖的智能手机比色检测系统的设计、制作与可行性分析。
J Biomed Opt. 2019 Feb;24(2):1-7. doi: 10.1117/1.JBO.24.2.027002.
9
ISO 15197:2013 Accuracy Evaluation of Two CE-Marked Systems for Self-Monitoring of Blood Glucose.ISO 15197:2013 两种获得CE认证的血糖自我监测系统的准确性评估
J Diabetes Sci Technol. 2015 Jul;9(4):934-5. doi: 10.1177/1932296815582223. Epub 2015 Apr 21.
10
A Low-Cost Inkjet-Printed Glucose Test Strip System for Resource-Poor Settings.一种适用于资源匮乏地区的低成本喷墨打印葡萄糖测试条系统。
J Diabetes Sci Technol. 2015 Jun 12;9(6):1275-81. doi: 10.1177/1932296815589755.

引用本文的文献

1
Availability, prices and affordability of self-monitoring blood glucose devices: surveys in six low-income and middle-income countries.自我监测血糖设备的可及性、价格及可负担性:六个低收入和中等收入国家的调查
BMJ Public Health. 2025 Feb 22;3(1):e001128. doi: 10.1136/bmjph-2024-001128. eCollection 2025 Jan.
2
Benefits of Usability Evaluation in the Development Process of Diabetes Technologies Using the Example of a Continuous Glucose Monitoring System Prototype.以连续血糖监测系统原型为例探讨糖尿病技术开发过程中可用性评估的益处。
J Diabetes Sci Technol. 2025 Sep;19(5):1293-1301. doi: 10.1177/19322968241238146. Epub 2024 Mar 13.

本文引用的文献

1
User requirements for non-invasive and minimally invasive glucose self-monitoring devices in low-income and middle-income countries: a qualitative study in Kyrgyzstan, Mali, Peru and Tanzania.用户对中低收入国家非侵入性和微创血糖自我监测设备的需求:吉尔吉斯斯坦、马里、秘鲁和坦桑尼亚的定性研究。
BMJ Open. 2024 Feb 17;14(2):e076685. doi: 10.1136/bmjopen-2023-076685.
2
Target product profile for readers of rapid diagnostic tests.快速诊断检测读者的目标产品概况。
Bull World Health Organ. 2023 May 1;101(5):331-340. doi: 10.2471/BLT.23.289728. Epub 2023 Mar 14.
3
Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres.
更新世界卫生组织外周中心下一代结核分枝杆菌药物敏感性检测的目标产品简介。
PLOS Glob Public Health. 2023 Mar 31;3(3):e0001754. doi: 10.1371/journal.pgph.0001754. eCollection 2023.
4
Development of a target product profile for a point-of-care cardiometabolic device.开发即时心血管代谢设备的目标产品特性。
BMC Cardiovasc Disord. 2021 Oct 9;21(1):486. doi: 10.1186/s12872-021-02298-7.
5
A framework for designing medical devices resilient to low-resource settings.设计医疗器械的框架,使其能够在资源匮乏的环境中具有弹性。
Global Health. 2021 Jun 22;17(1):64. doi: 10.1186/s12992-021-00718-z.
6
Products for Monitoring Glucose Levels in the Human Body With Noninvasive Optical, Noninvasive Fluid Sampling, or Minimally Invasive Technologies.用于人体无创光学、非侵入式流体采样或微创技术监测血糖水平的产品。
J Diabetes Sci Technol. 2022 Jan;16(1):168-214. doi: 10.1177/19322968211007212. Epub 2021 Jun 13.
7
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.
8
Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.制定耐抗生素淋病奈瑟菌诊断目标产品特性:专家共识。
PLoS One. 2020 Sep 1;15(9):e0237424. doi: 10.1371/journal.pone.0237424. eCollection 2020.
9
Medical Devices for Low- and Middle-Income Countries: A Review and Directions for Development.面向低收入和中等收入国家的医疗设备:综述与发展方向
J Med Device. 2020 Mar 1;14(1):010803. doi: 10.1115/1.4045910. Epub 2020 Feb 5.
10
Electronic clinical decision support algorithms incorporating point-of-care diagnostic tests in low-resource settings: a target product profile.电子临床决策支持算法纳入即时诊断检测在资源匮乏环境下:目标产品特征描述。
BMJ Glob Health. 2020 Feb 28;5(2):e002067. doi: 10.1136/bmjgh-2019-002067. eCollection 2020.